Three distributors of kratom, a popular and controversial herbal supplement, were issued warning letters from the Food and Drug Administration (FDA). According to the agency, the companies made deceptive marketing claims about the potential health benefits of kratom.
As reported by Reuters, the FDA is accusing Front Range Kratom, Revibe Inc., and Kratom Spot of engaging in “health fraud scams” by selling kratom products with unconfirmed medical claims. Without evidence to back it up, the companies marketed several health benefits of kratom, including pain relief, blood pressure reduction, and as an opioid addiction treatment, according to the agency.
Over 65 kratom products with names such as “Super Green Indo” and “50x Black Diamond Extract” were named in the FDA letter. The three companies have yet to comment about the administration’s letter.
0 comments :
Post a Comment